Annual Women’s Heart & Vascular Symposium 2021

Next Symposium October 2, 2021

Heart and vascular disease remain the leading contributor to morbidity and mortality among both women and men. While the decrease in mortality among women is well documented, the decline still lags behind that of men, with an alarming tendency towards an increase mortality rate among younger women.

Greater life expectancy for women, together with improvements in primary and secondary prevention of cardiovascular, will lead to a larger proportion of women living with disease. Substantial sex differences in the burden of different manifestations of cardiovascular disease, including coronary heart disease (CHD), stroke, heart failure, and peripheral artery disease, are widely recognized and must be addressed as new research and best practices are developed.

A SYMPOSIUM FOR ALL PROFESSIONALS CARING FOR WOMEN TODAY

Overview & Enduring Resources

Course Director Stephanie Coulter, MD

The Center for Women’s Heart & Vascular Health hosts this important, annual symposium to provide updates on the most current issues concerning cardiovascular disease in women. First held in 2010, this program is an accredited, full day symposium for all healthcare providers caring for women today including; cardiologists, surgeons, obstetricians/gynecologists, emergency medicine, internal medicine, family practice, endocrinologists, nurses and nurse practitioners about prevention, early diagnosis and treatment strategies for heart disease in women.

Related Learning & CME Offerings

Program Overview

Heart and vascular disease remain the leading contributor to morbidity and mortality among both women and men. While the decrease in mortality among women is well documented, the decline still lags behind that of men, with an alarming tendency towards an increase mortality rate among younger women.

Greater life expectancy for women, together with improvements in primary and secondary prevention of cardiovascular, will lead to a larger proportion of women living with disease. Substantial sex differences in the burden of different manifestations of cardiovascular disease, including coronary heart disease (CHD), stroke, heart failure, and peripheral artery disease, are widely recognized and must be addressed as new research and best practices are developed.

The Center for Women’s Heart & Vascular Health hosts this important, annual symposium to provide updates on the most current issues concerning cardiovascular disease in women. First held in 2010, this program is an accredited, day-long symposium for all healthcare providers caring for women today.

Target Audience

The goal of this symposium is to educate the physicians caring for women today including; cardiologists, cardiac surgeons, obstetricians/gynecologists, emergency medicine, internal medicine, family practice, endocrinologists, nurses and nurse practitioners about prevention, early diagnosis and treatment strategies for heart disease in women.

Faculty

Stephanie Coulter, MD Course Director

Director, Center for Women’s Heart & Vascular Health
Director, Cardiology Education, Texas Heart Institute
Program Director, Texas Heart Institute Cardiovascular Disease Fellowship at Baylor St. Luke’s Medical Center
Associate Director of Non-Invasive Cardiology
CHI Health—Baylor St. Luke’s Medical Center
Houston, TX

Briana Costello, MD Planning Committee

Texas Heart Institute
Texas Heart Medical Group
Houston, TX

Accreditation and Credit Designation

Accreditation

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Texas Heart Institute designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful completion is a passing grade of 70% on the assessment in the CME Evaluation.

Agenda

7:50 am                   Welcome  |  Stephanie Coulter, MD, FACC, FASE

8:05 am                KEYNOTE

Treatment-Risk Paradox in Blood Pressure Management | Robert A. Phillips, MD, PhD, FACC

Session I              Prevention Guidelines Update 2019

9:05 – 9:35             Non-Statins Treatment of LDL, Bempedoic Acid and PCSK9 Inhibitors | Salim Virani, MD, PhD

9:35 – 10:05             TG Treatment: Reduce-it vs Strength. | Peter Howard Jones, MD

10:05 – 10:25           CASE: Management of Lipids, Primary and Secondary Prevention | TBD

 10:25 – 10:35          Break

Session II             Imaging Updates in Women

10:35 – 11:05            Calcium Score and Aspirin | Eduardo Hernandez, MD

11:05 – 11:35             MINOCA  | R. David Fish, MD

11:35 – 12:05pm       Takotsubo | Stephanie Coulter, MD, FACC, FASE   

Lunch                                      

12:05 – 1:30pm        CASES | Aaron Bush, MD & Lauren Golden, MD

Session III           New Treatment Strategies & Outcomes in Women

1:30 – 2:00               Update of Diabetes Treatment | David Aguilar, MD                 

2:00 – 2:30              Heart Failure | Joseph G. Rogers, MD

2:30 – 2:40              LVADS and OHT in Women | Andrew Civitello, MD 

Session IV            Atrial Fibrillation

2:40 – 3:00             Afib Ablation is Sooner Better Than Later  | David Burkland, MD

3:00 – 3:20              Rhythm vs Rate: Has the Tide Changed Since Affirm? | Mehdi Razavi, MD

3:20 – 3:40              Bleeding Risk of AC | Joanna Molina Razavi, MD

3:40 – 4:00              Devices in Lea of AC: How Good are They? | Abdi Rasekh, MD

 4:00 pm                  Closing Remarks & Adjourn